Conservative Treatment Versus the Surgical Treatment of Diaphyseal Fractures of Humerus

December 19, 2012 updated by: Pelet Stephane, Hopital de l'Enfant-Jesus

Diaphyseal Fractures of the Humerus: A Prospective Cohort Study Comparing the Conservative Treatment and the Surgical Treatment.

The fracture of the humeral diaphysis is a condition that represents 2% of all fractures. The conservative treatment of diaphyseal fractures of the humerus has long been considered the only option and the surgical treatment was primarily reserved for displaced fractures with no contact of bone ends. However, for a few years there has been an upsurge of indications for the surgical treatment of diaphyseal fractures.

The purpose of this study is to compare the functional outcomes and the quality of life of surgically treated patients versus those who undergo a conservative treatment.

Study Overview

Study Type

Interventional

Enrollment (Actual)

4

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Quebec, Canada, G1J 1Z4
        • Hopital L'Enfant-Jesus
    • Quebec
      • Québec, Quebec, Canada, G1J 1Z4
        • CHA-Pavillon Enfant-Jésus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or female over 18 years
  • Fracture of the humeral diaphysis
  • Recent fracture (14 days or less)
  • Closed fracture
  • Signing of consent form

Exclusion Criteria:

  • Segmental fracture of the humerus
  • Fracture with proximal or distal intra articular extension
  • Open fracture
  • Polytrauma
  • Floating elbow or shoulder
  • Pathological fracture
  • Simultaneous fracture of both humerus
  • Associated vascular disease
  • Severe neuromuscular disorders such as Parkinson, hemiparesis, myasthenia gravis, muscular dystrophy, etc. ...
  • medical contraindication to surgery
  • severe central neurological disease disabling patient to fill in questionnaires (senile dementia, Alzheimer's, etc ...
  • Male or female unable to consent
  • Any other condition which prevents the assessor from fully monitoring the patient during study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Surgical treatment
Patients included in the surgical group will have surgery to treat the fracture.
Patients included in the surgical group will be divided into two subgroups according to the method of fixation chosen: plate and screws or nailing. Surgeries take place under general anesthesia and a prophylaxis antibiotic is administrated. The installation and the approach will be chosen by the surgeon according to his preferences. A thoraco brachial brace is placed on the patient at the end of the intervention and it remains in place for a period of 5 to 10 days (patient comfort). A gradual mobilization of the elbow and shoulder will be initiated by the patient at home. The addition of physical therapy will be decided by the surgeon and noted down accordingly.
Active Comparator: Conservative treatment group
Patients included in the conservative group will be taken to a plaster room where a Hanging Support System(HSS) brace will be installed by a qualified technician.
Patients included in the conservative group will be taken to a plaster room where the HSS brace will be installed by a qualified technician. Advice will be provided for the care, personal hygiene and clothing. The brace will be kept for a period of 6 to 12 weeks depending on the degree of healing of fracture. The maintenance of the proximal part (Brace) may be recommended by the surgeon. The mobilization will begin with exercises at home and whether the patient does physical therapy or not is the surgeon's choice.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Function and quality of life on DASH scale
Time Frame: 6 months after treatment
The function and quality of life are measured using the DASH scale six months after treatment.
6 months after treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DASH score
Time Frame: 6 months after treatment
The function and quality of life are measured using the DASH scale 6 months after treatment.
6 months after treatment
Return to professional activities
Time Frame: 3 months after treatment
It will be determined in days after surgery, to rates of 50% and 100% of the usual workload.
3 months after treatment
SF-36 score
Time Frame: 6 months after treatment
This score will help validate the impact on quality of life of both types of treatment. It includes 36 items asking about the recent quality of life. This will also enable better understanding of the impact in real time on the functional level.
6 months after treatment
DASH score
Time Frame: 12 months after treatment
The function and quality of life are measured using the DASH scale 12 months after treatment.
12 months after treatment
SF-36 score
Time Frame: 12 months after treatment
This score will help validate the impact on quality of life of both types of treatment. It includes 36 items asking about the recent quality of life. This will also enable better understanding of the impact in real time on the functional level.
12 months after treatment
Proportion of additional surgeries
Time Frame: 12 months after surgery
The evaluation of the rate of complications such as infection, implant removal, non-union, implant failure or malunion which necessitate additional surgery.
12 months after surgery
Radiological loss of reduction
Time Frame: 2 weeks after treatment

The main observed displacements occur in varus and are measured on an AP view of the humerus. Initial displacements are tolerated up to 20 degrees in varus and in flexion.

We measure the proportion of patients who experienced worsening of the deformity of more than 5 degrees on both levels.

2 weeks after treatment
Radiological loss of reduction
Time Frame: 6 weeks after treatment

The main observed displacements occur in varus and are measured on an AP view of the humerus. Initial displacements are tolerated up to 20 degrees in varus and in flexion.

We measure the proportion of patients who experienced worsening of the deformity of more than 5 degrees on both levels.

6 weeks after treatment
Radiological loss of reduction
Time Frame: 12 weeks after treatment

The main observed displacements occur in varus and are measured on an AP view of the humerus. Initial displacements are tolerated up to 20 degrees in varus and in flexion.

We measure the proportion of patients who experienced worsening of the deformity of more than 5 degrees on both levels.

12 weeks after treatment
Radiological loss of reduction
Time Frame: 6 months after treatment

The main observed displacements occur in varus and are measured on an AP view of the humerus. Initial displacements are tolerated up to 20 degrees in varus and in flexion.

We measure the proportion of patients who experienced worsening of the deformity of more than 5 degrees on both levels.

6 months after treatment
Union rate
Time Frame: 12 weeks after treatment

The union is defined by the presence of a strong radiological callus associated with lack of pain at the fracture site. The humerus unifies in an average of three months. It is considered non-union if it is not unified after six months, and it is classified as delayed union between 3 and 6 months.

The rates will be presented by the number of patients with non-union in each group.

12 weeks after treatment
Union rate
Time Frame: 6 months after treatment

The union is defined by the presence of a strong radiological callus associated with lack of pain at the fracture site. The humerus unifies in an average of three months. It is considered non-union if it is not unified after six months, and it is classified as delayed union between 3 and 6 months.

The rates will be presented by the number of patients with non-union in each group.

6 months after treatment
Rates of complication
Time Frame: within the first year following treatment
The main complications recognized in the treatment of humerus fractures are: infection, nerve damage, malunion and non-unions. Each complication will be recorded and reported.
within the first year following treatment
Pain on visual analogue pain scale (VAS)
Time Frame: 2 weeks after treatment
The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.
2 weeks after treatment
Pain on VAS
Time Frame: 6 weeks after treatment
The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.
6 weeks after treatment
Pain on VAS
Time Frame: 12 weeks after treatment
The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.
12 weeks after treatment
Pain on VAS
Time Frame: 6 months after treatment
The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.
6 months after treatment
Pain on VAS
Time Frame: 12 months after treatment
The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.
12 months after treatment
Measurement of range of motion of the shoulder
Time Frame: 2 weeks after treatment
Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).
2 weeks after treatment
Measurement of range of motion of the shoulder
Time Frame: 6 weeks after treatment
Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).
6 weeks after treatment
Measurement of range of motion of the shoulder
Time Frame: 12 weeks after treatment
Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).
12 weeks after treatment
Measurement of range of motion of the shoulder
Time Frame: 6 months after treatment
Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).
6 months after treatment
Measurement of range of motion of the shoulder
Time Frame: 12 months after treatment
Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).
12 months after treatment
Measurement of range of motion of the elbow
Time Frame: 2 weeks after treatment
Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).
2 weeks after treatment
Measurement of range of motion of the elbow
Time Frame: 6 weeks after treatment
Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).
6 weeks after treatment
Measurement of range of motion of the elbow
Time Frame: 12 weeks after treatment
Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).
12 weeks after treatment
Measurement of range of motion of the elbow
Time Frame: 6 months after treatment
Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).
6 months after treatment
Measurement of range of motion of the elbow
Time Frame: 12 months after treatment
Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).
12 months after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stéphane Pelet, MD, PhD, Hôpital de l'Enfant-Jésus

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Anticipated)

December 1, 2012

Study Completion (Anticipated)

July 1, 2014

Study Registration Dates

First Submitted

May 3, 2010

First Submitted That Met QC Criteria

May 3, 2010

First Posted (Estimate)

May 5, 2010

Study Record Updates

Last Update Posted (Estimate)

December 20, 2012

Last Update Submitted That Met QC Criteria

December 19, 2012

Last Verified

December 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Humeral Diaphysis Fracture

Clinical Trials on Plate and screws or nailing

Subscribe